Search results
Results From The WOW.Com Content Network
Radiation-induced cognitive decline describes the possible correlation between radiation therapy and cognitive impairment. Radiation therapy is used mainly in the treatment of cancer. Radiation therapy can be used to cure, care or shrink tumors that are interfering with quality of life. Sometimes radiation therapy is used alone; other times it ...
Medication Appropriateness Tool for Comorbid Health conditions during Dementia. The Medication Appropriateness Tool for Comorbid Health conditions during Dementia ( MATCH-D) criteria supports clinicians to manage medication use specifically for people with dementia without focusing only on the management of the dementia itself. [1] [2]
Medicare generally doesn’t offer much to assist the 6.9 million Americans over age 65 with dementia or their 11.5 million unpaid family caregivers. But a new pilot program called the GUIDE Model ...
In community samples, cutoff scores for likely dementia have ranged from 3.3 and above to 3.6 and above, while in patient samples the cutoff scores have ranged from 3.4 and above to 4.0 and above. [3] To improve the detection of dementia, the IQCODE can be used in combination with the Mini-Mental State Examination.
Now, researchers from the Montefiore Health System have created a five-minute assessment for dementia that can be done by medical staff, making it accessible to a wide range of people. The test is ...
One in four people with dementia experience symptoms for more than two years before they are diagnosed, according to new research. A study for the Alzheimer’s Society suggests signs of dementia ...
Alzheimer's disease (AD) is a neurodegenerative disease and the most common cause of dementia; it usually occurs in old age. Familial Alzheimer's disease (FAD or EOFAD for early onset) is an inherited and uncommon form of AD. Familial AD usually strikes earlier in life, defined as before the age of 65. FAD usually implies multiple persons ...
Purpose. test cognitive impairment. The Addenbrooke's Cognitive Examination (ACE) and its subsequent versions (Addenbrooke's Cognitive Examination-Revised, ACE-R [ 1] and Addenbrooke's Cognitive Examination III, ACE-III) are neuropsychological tests used to identify cognitive impairment in conditions such as dementia .